An Orally Efficacious Thyrotropin Receptor Ligand Inhibits Growth and Metastatic Activity of Thyroid Cancers.
Sarkar R, Bolel P, Kapoor A, Eliseeva E, Dulcey AE, Templin JS, Wang AQ, Xu X, Southall N, Klubo-Gwiezdzinska J, Neumann S, Marugan JJ, Gershengorn MC.
Sarkar R, et al. Among authors: wang aq.
J Clin Endocrinol Metab. 2024 Aug 13;109(9):2306-2316. doi: 10.1210/clinem/dgae114.
J Clin Endocrinol Metab. 2024.
PMID: 38421044
Free PMC article.